Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

Previous Episode: FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

Next Episode: Get to Know the DLMP Chair: Eric Hsi, M.D.

Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.

(00:32)
Can you tell us a little bit about yourself and your background?

(01:46)
Can you please provide an overview of laboratory testing for substance use disorders and specifically Mayo Clinic's new oral fluid controlled substance monitoring option?

(03:47)
Which patients should have this testing and when should it be performed?

(05:16)
What alternative test options are available and how do these compare?

(06:31)
How are the results used in patient care?

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

Answers from the Lab